Break in FII selling after 38 days, foreign investors buy Rs 9947 cr on Nov 25

Foreign Institutional Investors (FIIs) turned net buyers in the equity markets on Monday, November 25, purchasing Rs 9,947.55 crore worth of equities (provisional data). This marked a significant shift, ending a streak of 38 consecutive sessions of net selling, providing a much-needed boost to the market sentiment.

FII and DII Trading Activity

In contrast, Domestic Institutional Investors (DIIs) became net sellers on the same day, offloading shares worth Rs 6,907.97 crore (provisional). DIIs had been net buyers for 13 consecutive sessions prior to this shift. 

During Monday’s trading session, DIIs bought Rs 17,625 crore worth of equities but sold Rs 24,533 crore in shares, highlighting a significant change in their market strategy.

Also Read Stocks To Watch: Reliance Industries, Hero MotoCorp, Crompton Greaves, Honasa Consumer, Adani Total Gas, Hindustan Zinc, Grasim U-turn: CLSA backs India over China Cipla Share Price Today Highlights, 14 Nov, 2024: Cipla closes 0.29% lower Benchmark indices expected to trade in 23550-24,550 range amidst volatility, says Religare Broking

Also ReadTelecom stocks like Vodafone Idea, Indus Tower zoom up 14% after Cabinet approves waiving off bank guarantees

FIIs purchased Rs 85,252 crore worth of equities and sold Rs 75,305 crore worth of shares, signaling a shift in their approach after weeks of selling. The overall trading activity saw a balance in buying and selling, with the net buying by FIIs counteracting the selling by DIIs.

Year-to-Date Inflows Overview

For the year so far, FIIs have net sold Rs 2.84 lakh crore worth of equities, while DIIs have net bought Rs 5.56 lakh crore in shares. In the past week, FIIs offloaded Rs 11,414 crore in shares, taking their total net selling to Rs 1.55 lakh crore since October. The data suggests that FIIs have been cautious in their approach amid broader market fluctuations.

What Brought the Massive FIIs Buying?

HDFC Bank was one of the major gainers in Monday’s trading session, seeing a 2.3% increase in its stock price, closing at Rs 1,785.6 per share. The boost came following the MSCI (Morgan Stanley Capital International) index rejig, where HDFC Bank saw a much-anticipated increase in its weightage within the index.

Estimated $1.88 Billion Passive Inflows

This weightage adjustment was expected to bring in an estimated $1.88 billion in passive inflows to the bank’s stock.

 » Read More

Related Articles

Q3FY25 Results: Thyrocare reports 30 percent rise in profit; Revenue stood at Rs 165.9 Crore

Thyrocare on Thursday announced its financial results for the quarter and nine months ended December 31, 2024. According to the company’s statement, the diagnostics major reported revenue of Rs. 165.9 Cr in Q3FY25 with a growth of 23 percent YoY. According to the company’s statement, Thyrocare’s consolidated revenue increased by 23% year-over-year (YoY) with Pathology

Gold prices soar to new peak of Rs 82,900 per 10 gm; silver drops by Rs 500

Gold prices rose Rs 170 to hit a fresh record high of Rs 82,900 per 10 grams in the national capital on Thursday amid a positive global trend, according to the All India Sarafa Association. The precious metal had closed at Rs 82,730 per 10 grams on Wednesday. In about one year, the precious metal

Good news for taxpayers! Govt removes THESE difficulties to ensure more tax cases are settled – Check details!

Good news for taxpayers! The Finance Ministry has made some changes to the Direct Tax Vivad Se Vishwas Scheme, 2024, removing “difficulties” that arose due to certain situations for taxpayers. This update in the scheme will bring relief to taxpayers who wanted to apply for the scheme but could not do so earlier. “CBDT…makes the

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Stay Connected

0FansLike
0FollowersFollow
0SubscribersSubscribe
- Advertisement -

Latest Articles

Q3FY25 Results: Thyrocare reports 30 percent rise in profit; Revenue stood at Rs 165.9 Crore

Thyrocare on Thursday announced its financial results for the quarter and nine months ended December 31, 2024. According to the company’s statement, the diagnostics major reported revenue of Rs. 165.9 Cr in Q3FY25 with a growth of 23 percent YoY. According to the company’s statement, Thyrocare’s consolidated revenue increased by 23% year-over-year (YoY) with Pathology

Gold prices soar to new peak of Rs 82,900 per 10 gm; silver drops by Rs 500

Gold prices rose Rs 170 to hit a fresh record high of Rs 82,900 per 10 grams in the national capital on Thursday amid a positive global trend, according to the All India Sarafa Association. The precious metal had closed at Rs 82,730 per 10 grams on Wednesday. In about one year, the precious metal

Good news for taxpayers! Govt removes THESE difficulties to ensure more tax cases are settled – Check details!

Good news for taxpayers! The Finance Ministry has made some changes to the Direct Tax Vivad Se Vishwas Scheme, 2024, removing “difficulties” that arose due to certain situations for taxpayers. This update in the scheme will bring relief to taxpayers who wanted to apply for the scheme but could not do so earlier. “CBDT…makes the

Johnnie Walker-maker United Spirits posts Q3 profit decline of 4.29% to Rs 335 crore, revenue up 11.06% YoY

United Spirits, which makes Smirnoff vodka, on Thursday reported a profit of Rs 335 crore for the third quarter of FY25, posting a decline of 4.29 per cent in comparison to Rs 350 crore during the corresponding quarter of previous financial year. It posted revenue from operations at Rs 7,732 crore, reporting a growth of

Q3FY25: Mankind Pharma’s revenue up by 24 percent to Rs 3,230 Crore; Profit at Rs 380 crore

Pharma major Mankind Pharma on Thursday reported its financial results for the third quarter and nine months ended 31 st December 2024. The company reported revenue from Operations at Rs. 3,230 Cr, up by 24% YoY and domestic revenue at INR 2,773 Cr, up 17%, Exports at INR 457 Cr, up 121% YoY. The company’s